[1] Moerman DE. The meaning response:thinking about placebos[J]. Pain Pract, 2006, 6(4):233-236.
[2] Moerman DE. The meaning response and the ethics of avoiding placebos[J]. Eval Health Prof,2002,25(4):399-409.
[3] Moerman DE. Agreement and meaning:rethinking consensus analysis[J]. J Ethnopharmacol,,2007,112(3):451-460.
[4] Moerman DE,Jonas WB. Toward a research agenda on placebo[J]. Adv Mind Body Med,2000,16(1):33-46.
[5] Moerman DE,Jonas WB. Deconstructing the placebo effect and finding the meaning response[J]. AnnIntern Med,2002,136(6):471-476.
[6] 王莉,邓勋,贺帅,等. 高血压患者药物品牌内涵响应对用药选择的影响[J]. 今日药学,2010,20(5):35-38.
[7] 曹贤芹,张静,庄丽琼,等. 门诊患者药物品牌内涵响应对用药选择及依从性的影响[J]. 今日药学,2011,21(7):444-446.
[8] 葛悦,朱珠. 我院部分国产药与进口(合资)药使用情况简析[J].中国医院药学杂志, 2007,27(11):1576-1578.
[9] Cai J,Ye MR,Fei CH,et al. Impact of brand-name drug worship and expectation psychology on antidepressant efficacy[J].Int J Clin Exper Med,2013,6(8):724-726.
[10] Kesselheim AS,Gagne JJ,Franklin JM,et al. Variations in patients' perceptions and use of generic drugs:results of a national survey[J]. J Gen Intern Med,2016, 31(6):609-614.
[11] Drozdowska A,Hermanowski T. Exploring the opinions and experiences of patients with generic substitution:a representative study of Polish society[J]. Int J Clin Pharm,2015,37(1):68-75.
[12] Patel M,Slack M,Cooley J,et al. A cross-sectional survey of pharmacists to understand their personal preference of brand and generic over-the-counter medications used to treat common health conditions[J]. J Pharm Polic Pract,2016,9(1):1-8.
[13] Carbon M,Correll CU. Rational use of generic psychotropic drugs[J]. CNS Drugs,2013, 27(5):353-365.
[14] Desmarais JE,Beauclair L,Margolese HC. Switching from brand-name to generic psychotropic medications:a literature review[J]. CNS Neurosci Ther,2011, 17(6):750-760.
[15] Margolese HC,Wolf Y,Desmarais JE,et al. Loss of response after switching from brand name to generic formulations:three cases and a discussion of key clinical considerations when switching[J]. Int Clin Psychopharmacol,2010,25(3):180-182.
[16] Pae CU,Misra A,Ham BJ,et al. Paroxetine mesylate:comparable to paroxetine hydrochloride[J]. Expert Opin Pharmacother,2010,11(2):185-193.
[17] Van Ameringen M,Mancini C,Patterson B,et al. Symptom relapse following switch from Celexa to generic citalopram:an anxiety disorders case series[J]. J Psychopharmacol (Oxford),2007,21(5):472-476.
[18] Cessak G,Rokita K,Dabrowska M,et al. Therapeutic equivalence of antipsychotics and antidepressants-A systematic review[J]. Pharmacol Rep,2016,68(2):217-223.